Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer
暂无分享,去创建一个
Ugo Pastorino | Elena Landoni | Rosalba Miceli | Gabriella Sozzi | U. Pastorino | M. Colombo | M. Mensah | G. Sozzi | L. De Cecco | M. Callari | R. Miceli | F. Andriani | L. Roz | F. Facchinetti | E. Tagliabue | E. Landoni | Mario Paolo Colombo | Loris De Cecco | Maurizio Callari | M. Giussani | Elda Tagliabue | Federica Facchinetti | Luca Roz | Francesca Andriani | Marta Giussani | Mavis Mensah | Mavis Mensah
[1] R. Miceli,et al. Extracellular matrix proteins as diagnostic markers of breast carcinoma , 2018, Journal of cellular physiology.
[2] D. Carbone,et al. Blood-based biomarkers in lung cancer: prognosis and treatment decisions. , 2017, Translational lung cancer research.
[3] Ash A. Alizadeh,et al. Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. , 2017, Cancer discovery.
[4] J. Hung,et al. Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1/snail in non-small cell lung cancer , 2017, Oncotarget.
[5] M. Cheng,et al. Clinicopathological and prognostic significance of circulating tumor cells in patients with lung cancer: a meta-analysis , 2017, Oncotarget.
[6] P. Pandolfi,et al. Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling. , 2017, Cancer research.
[7] F. Ma,et al. Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis , 2017, Molecular and clinical oncology.
[8] G. Botti,et al. Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer. , 2017, Translational lung cancer research.
[9] D. Xie,et al. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing , 2017, Clinical Cancer Research.
[10] M. Sukkar,et al. The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease , 2017, British journal of pharmacology.
[11] Tuan Zea Tan,et al. A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets. , 2016, Cancer letters.
[12] J. Karlsson,et al. The extracellular matrix – the under‐recognized element in lung disease? , 2016, The Journal of pathology.
[13] M. Colombo,et al. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity. , 2016, Cell reports.
[14] Hua-Chuan Zheng,et al. SPARC expression in gastric cancer predicts poor prognosis: Results from a clinical cohort, pooled analysis and GSEA assay , 2016, Oncotarget.
[15] Changhong Miao,et al. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance. , 2016, Oncology reports.
[16] B. Nemesure,et al. Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment Modalities , 2016, Medical science monitor : international medical journal of experimental and clinical research.
[17] M. Callari,et al. Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types. , 2015, Seminars in cancer biology.
[18] Giuseppe Merlino,et al. Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression. , 2015, Seminars in cancer biology.
[19] U. Pastorino,et al. Conversion to stem‐cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells , 2015, Molecular oncology.
[20] I. Rizos,et al. Development of novel real-time PCR methodology for quantification of COL11A1 mRNA variants and evaluation in breast cancer tissue specimens , 2015, BMC Cancer.
[21] P. Carmeliet,et al. The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts. , 2015, Cell reports.
[22] V. Prod’homme,et al. Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis , 2015, Nature Communications.
[23] E. White. Lung extracellular matrix and fibroblast function. , 2015, Annals of the American Thoracic Society.
[24] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[25] Daniel S. Puperi,et al. Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma. , 2015, The Journal of clinical investigation.
[26] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[27] Wei Wang,et al. Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer , 2014, Scientific Reports.
[28] V. Weaver,et al. The extracellular matrix modulates the hallmarks of cancer , 2014, EMBO reports.
[29] Daniel Öhlund,et al. Fibroblast heterogeneity in the cancer wound , 2014, The Journal of experimental medicine.
[30] M. Karsdal,et al. Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer , 2014, Cancer medicine.
[31] C. la Vecchia,et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] J. R. de los Toyos,et al. Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer , 2013, PloS one.
[33] M. Junttila,et al. Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.
[34] S. Ménard,et al. Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress , 2013, PloS one.
[35] Mats Lambe,et al. CD99 is a novel prognostic stromal marker in non‐small cell lung cancer , 2012, International journal of cancer.
[36] Yuquan Wei,et al. Chemical proteomics: terra incognita for novel drug target profiling , 2012, Chinese journal of cancer.
[37] J. Shao,et al. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis , 2012, Journal of Translational Medicine.
[38] C. Croce,et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer , 2011, Proceedings of the National Academy of Sciences.
[39] B. Celli,et al. Gender Differences in Plasma Biomarker Levels in a Cohort of COPD Patients: A Pilot Study , 2011, PloS one.
[40] Rafael Sirera,et al. The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[41] Mikala Egeblad,et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.
[42] R. Hynes. The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.
[43] R. Kalluri,et al. Tumor stroma derived biomarkers in cancer , 2009, Cancer and Metastasis Reviews.
[44] Chau-Chyun Sheu,et al. Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. , 2006, Oncology reports.
[45] W. Mcgregor,et al. Gender difference in the activity but not expression of estrogen receptors α and β in human lung adenocarcinoma cells , 2006 .
[46] E Helene Sage,et al. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. , 2003, Cancer research.
[47] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[48] R. Simon,et al. Flexible regression models with cubic splines. , 1989, Statistics in medicine.
[49] L. Gasiorowski,et al. In-vivo isolation of circulating tumor cells in non-small cell lung cancer patients by CellCollector. , 2017, Neoplasma.
[50] W. Mcgregor,et al. Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. , 2006, Endocrine-related cancer.
[51] Yang Zhang,et al. Chinese a Nti鄄 Cancer a Ssociation , 2022 .